Lenacapavir Tablet Clinical Trials
2 recruitingDrug
Phase 31
Showing 1–2 of 2 trials
Recruiting
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
HIV Infections
Gilead Sciences3,000 enrolled4 locationsNCT07473778
Recruiting
Phase 3
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
Gilead Sciences350 enrolled31 locationsNCT07047716